Fanhua Total Long Term Liabilities 2010-2024 | AIFU

Fanhua total long term liabilities from 2010 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
Fanhua Annual Total Long Term Liabilities
(Millions of US $)
2023 $97
2022 $59
2021 $59
2020 $30
2019 $64
2018 $31
2017 $13
2016 $13
2015 $14
2014 $13
2013 $12
2012 $12
2011 $12
2010 $7
2009 $3
Fanhua Quarterly Total Long Term Liabilities
(Millions of US $)
2023-12-31 $97
2023-09-30 $82
2023-06-30 $78
2023-03-31 $59
2022-12-31 $59
2022-09-30 $56
2022-06-30 $56
2022-03-31 $57
2021-12-31 $59
2021-09-30 $47
2021-06-30 $42
2021-03-31 $38
2020-12-31 $30
2020-09-30 $69
2020-06-30 $65
2020-03-31 $64
2019-12-31 $64
2019-09-30 $67
2019-06-30 $74
2019-03-31 $68
2018-09-30 $30
2018-06-30
2017-12-31 $13
2017-09-30 $14
2017-06-30 $13
2017-03-31 $13
2016-12-31 $13
2016-09-30 $13
2016-06-30 $13
2016-03-31 $13
2015-12-31 $14
2015-09-30 $14
2015-06-30 $14
2015-03-31 $13
2014-12-31 $13
2014-09-30 $13
2014-06-30 $12
2014-03-31 $12
2013-12-31 $12
2013-09-30 $12
2013-06-30 $12
2013-03-31 $12
2012-12-31 $12
2012-09-30 $12
2012-06-30 $12
2012-03-31 $12
2011-12-31 $12
2011-09-30 $8
2011-06-30 $7
2011-03-31 $7
2010-12-31 $7
2010-09-30 $7
2010-06-30 $6
2010-03-31 $4
2009-12-31 $3
2009-09-30 $3
2009-06-30 $34
2009-03-31 $15
Sector Industry Market Cap Revenue
Finance INS-BROKERS $0.086B $0.450B
Fanhua Inc. is a provider of financial services. Its product and services comprises property, casualty and life insurance products and insurance claims adjusting services. The company's online segment includes CNpad, a mobile sales support application, Baoxian.com, an online entry portal for comparing and purchasing health, accident, travel and homeowner insurance products and eHuzhu a non-profit online mutual aid. Fanhua Inc. formerly known as CNinsure Inc. is headquatered in Guangzhou, China.
Stock Name Country Market Cap PE Ratio
Top KingWin (WAI) China $0.008B 0.00
S&W Seed (SANW) United States $0.006B 0.00
Invo BioScience (NAYA) United States $0.004B 0.00
Ocuphire Pharma (IRD) $0.000B 0.00